product name |
eptifibatide; |
sequence |
mpr-har-gly-asp-trp-pro-cys-nh2 [3-carbamoyl-11-{4-[(diaminomethylidene)amino]butyl}-20-(1h-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7h-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid; [(1s,4r,12s,18s,21s)-12-(4-carbamimidamidobutyl)-4-carbamoyl-21-(1h-indol-3-ylmethyl)-2,10,13,16,19,22-hexaoxo-6,7-dithia-3,11,14,17,20,26-hexaazabicyclo[21.2.1]hexacos-18-yl]acetic acid; map-lys-gly-asp-trp-pro-cys-nh2; integrelin; n6-(aminoiminomethyl)-n2-(3-mercapto-1-oxopropyl-l-lysylglycyl-l-a-aspartyl-l-tryptophyl-l-prolyl-l-cysteinamide; [(3r,11s,17s,20s,25as)-11-(4-carbamimidamidobutyl)-3-carbamoyl-20-(1h-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7h-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid |
cas no. |
148031-34-9 |
molecular formula |
c35h49n11o9s2 |
molecular weight |
832.4 |
appearance |
white slightly yellwish powder |
specific rotation[20/d] |
-75.0~-95.0°(c=1,1%hac) |
amino acids composition |
± 10% |
peptide purity (by hplc) |
≥98% by area integration |
related substance (by hplc) |
total impurities (%)≤2.0% largest single impurity (%)≤ 1.0% |
water content (karl fischer) |
≤8.0% |
peptide content(n determination) |
≥80% |
acetate content |
≤15% |
ir spectrum |
in accordance |